Observational study on the prevalence and risk factors of patients with hyperkalaemia in Brazil

Trial Identifier:	D9480R00075
Sponsor:	AstraZeneca
Start Date:	March 2026
Primary Completion Date:	September 2026
Study Completion Date:	September 2026
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Curitiba, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.